The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma.

D'Angelo, SP; Ganjoo, KN; Blay, JY; Valverde, C; Araujo, DM; Razak, ARA; Le Cesne, A; Schuetze, S; Wagner, MJ; Attia, S; Forcade, E; Druta, M; Pollack, S; Bai, J; Lunt, C; Sun, A; Yule, M; McAlpine, C; Williams, D; Van Tine, BA

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):